AVEO Oncology
AVEO
#7213
Rank
HK$4.08 B
Marketcap
HK$117.48
Share price
0.00%
Change (1 day)
173.29%
Change (1 year)

Market capitalization of AVEO Oncology (AVEO)

Last known market cap: HK$4.08 Billion

On March 24, 2023 AVEO Oncology had a market cap of HK$4.08 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AVEO Oncology from 2010 to 2023

End of year Market Cap

Year Marketcap Change
2023HK$4.07 B0.29%
2022HK$4.06 B223.02%
2021HK$1.25 B-2.45%
2020HK$1.28 B64.8%
2019HK$0.78 B-50.66%
2018HK$1.58 B-38.55%
2017HK$2.57 B711.9%
2016HK$0.31 B-44.09%
2015HK$0.56 B66.74%
2014HK$0.34 B-53.65%
2013HK$0.73 B-73.09%
2012HK$2.73 B-52.67%
2011HK$5.77 B42.47%
2010HK$4.05 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Eli Lilly
LLY
HK$6.420 T 157,114.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.471 T 35,940.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$215.95 B 5,187.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$634.26 B 15,430.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$943.78 B 23,009.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
HK$1.75 B-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA